Literature DB >> 22562806

Cytokine and chemokine ligand expression in cutaneous lupus erythematosus.

Thilo Gambichler1, Zanna Genc, Marina Skrygan, Nina Scola, Christian Tigges, Sarah Terras, Falk G Bechara, Alexander Kreuter.   

Abstract

There is increasing evidence that cytokines as well as chemokines are important players in the pathogenesis of lupus erythematosus (LE). We aimed to compare cytokine and chemokine profiles in different types of cutaneous LE. We investigated lesional mRNA and protein expression of various cytokines and chemokines in patients with chronic discoid LE (CDLE, n=15), subacute cutaneous LE (SCLE, n=11), and lupus erythematosus tumidus (LET, n=21). TNF-α, INF-γ, TGF-β, IL-6, IL-10, IL-12p40, CXCL9, and CXCL10 mRNA expression were significantly increased in SCLE when compared to CDLE. Moreover, LET also showed significantly increased mRNA expression of TNF-α, TGF-β, IL-10, IL-12p40 and CXCL9, as compared to CDLE. In all LE subtypes, CXCL9 and CXCL10 mRNA expression significantly correlated with INF-γ mRNA expression, as indicated by r-values ranging from 0.71 - 0.87. Immunohistochemistry for TNF-α, INF-γ, and IL-10 gave support to our RT-PCR results. In conclusion, our results suggest that T helper 1, as well as T helper 2 cytokines are differentially expressed in CDLE, SCLE, and LET. Compared to CDLE, the highest cytokine and chemokine ligand profiles are found in SCLE followed by LET. Our correlation studies also support the importance of an IFN-driven inflammation in cutaneous LE.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22562806     DOI: 10.1684/ejd.2012.1725

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  7 in total

1.  Bioinformatics analyses of gene expression profile identify key genes and functional pathways involved in cutaneous lupus erythematosus.

Authors:  Zhen-Yu Gao; Lin-Chong Su; Qing-Chao Wu; Jiao-E Sheng; Yun-Long Wang; Yu-Fang Dai; An-Ping Chen; San-Shan He; Xia Huang; Guo-Qing Yan
Journal:  Clin Rheumatol       Date:  2021-09-23       Impact factor: 2.980

2.  JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases.

Authors:  Ana Karina Alves de Medeiros; Reinhart Speeckaert; Eline Desmet; Mireille Van Gele; Sofie De Schepper; Jo Lambert
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

3.  Lupus erythematosus tumidus: clinical perspectives.

Authors:  Nikolaos Patsinakidis; Ocko Kautz; Bernhard F Gibbs; Ulrike Raap
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-10-01

4.  Molecular Profiling of Cutaneous Lupus Lesions Identifies Subgroups Distinct from Clinical Phenotypes.

Authors:  Celine C Berthier; Lam C Tsoi; Tamra J Reed; Jasmine N Stannard; Emily M Myers; Rajaie Namas; Xianying Xing; Stephanie Lazar; Lori Lowe; Matthias Kretzler; Johann E Gudjonsson; J Michelle Kahlenberg
Journal:  J Clin Med       Date:  2019-08-17       Impact factor: 4.241

Review 5.  The Genetic Landscape of Cutaneous Lupus Erythematosus.

Authors:  Henry W Chen; Grant Barber; Benjamin F Chong
Journal:  Front Med (Lausanne)       Date:  2022-06-02

6.  Site-specific analysis of inflammatory markers in discoid lupus erythematosus skin.

Authors:  Ryan B Thorpe; Anna Gray; Kirthi R Kumar; Joseph S Susa; Benjamin F Chong
Journal:  ScientificWorldJournal       Date:  2014-03-11

7.  Caveolin-1 regulates chemokine receptor 5-mediated contribution of bone marrow-derived cells to dermal fibrosis.

Authors:  Rebecca Lee; Beth Perry; Jonathan Heywood; Charles Reese; Michael Bonner; Corey M Hatfield; Richard M Silver; Richard P Visconti; Stanley Hoffman; Elena Tourkina
Journal:  Front Pharmacol       Date:  2014-06-11       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.